Finance
Victoire Aubry Head of Finance, IT and Work Environment
« As a leading real estate player in Greater Paris, Icade is the 5th largest listed property investor in France »
EPA: ICAD
44,26 EUR 1,02
30 Oct à 17:35
Currency
EUR
Market
Paris (EUR)
ISIN code
FR0000035081
Ticker code
ICAD
Industry
SCPI : biens industriels et bureautiques
Market Capitalization
3,234,851,159
Number of shares
74,535,741
SRD
Eligible
ICB
ICB Industrial & Office REITs, 8671
Indices
SBF 80, SBF 120, Euronext 100, Dow Jones Stoxx Europe 600, Dow Jones Euro Stoxx, CAC Mid&Small, CAC Allshares, CAC All-Tradable, CAC Mid 60, CAC Financials, CAC RE Inv Trusts, IEIF SIIC France
23 November 2020
22 October 2020
Before the market opens
21 July 2020
24 April 2020
24 April 2020
3 April 2020
17 February 2020
24 September 2020
After their Reprendre Racines project was chosen by SNCF and the City of Paris as part of the Reinventing Paris 2 competition, Icade and SEGRO have reached a significant milestone by signing preliminary agreements to acquire land for the site of the Gobelins train station in the 13th district of Paris.
Read the press release10 September 2020
Less than a year after launching its inaugural bond, Icade Santé has today announced the successful issue of its first social bond, totalling €600m and maturing in 2030 with a fixed coupon of 1.375%. These funds were raised with a 155-bp spread over the reference rate.
Read the press release7 September 2020
Icade Santé has today acquired the shares held by one of its minority shareholders representing 2.51% of its own capital. These shares were immediately cancelled as part of a reduction of Icade Santé’s share capital. This transaction has increased Icade’s exposure to the healthcare asset class, with its ownership interest in Icade Santé now standing at 58.3% vs. 56.8% earlier.
Read the press releaseBy clicking on this link, you will find the interactive version of Icade's 2019 Universal Registration Document.
Contact
Anne-Sophie Lanaute
Head of financial communication and investor relations
Investor Relations
